Company intelligence / Profile preview

DeveloGen AG

Göttingen, Lower Saxony, Germanydevelogen.com ↗
Ownership
Private
Employees
~100
Development stage
Phase 3
01

Overview

DeveloGen was a German biopharmaceutical company specializing in the discovery and development of novel therapeutics for metabolic and endocrine diseases such as type I/II diabetes and obesity. Its pipeline included small molecules targeting insulin resistance, growth factors promoting beta-cell regeneration/survival, a somatostatin analogue in early clinical trials for acromegaly/carcinoid tumors/diabetic retinopathy, as well as DiaPep277—a synthetic peptide immunomodulator that reached pivotal Phase III trials through partnership with Andromeda/Teva. The company was acquired by Evotec AG in July of 2010.

Therapeutic areas
Endocrinology
Modalities
Small moleculesPeptides (e.g., synthetic peptide immunomodulators)Growth factorsSomatostatin analogues
Industry
Biotech
02

Drug pipeline

4 assets

DiaPep277

Phase 3
Indications
Type 1 diabetes

3 more assets in the full pipeline.

Request access →
03

Partnerships

Boehringer Ingelheim (small molecules/type II diabetes)Andromeda Biotech/Teva Pharmaceutical Industries Ltd. ("DiaPep277" partnership).

Beyond the preview

Go deeper on DeveloGen AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeveloGen AG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call